# A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients

> **NCT00002201** · NA · COMPLETED · sponsor: **Abbott**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Ritonavir
- **DRUG:** Nelfinavir mesylate

## Key facts

- **NCT ID:** NCT00002201
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002201, "A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00002201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*